Novartis sees 20 per cent profit rise

Basel-based Novartis said revenues rose by 10 per cent Keystone

The Swiss pharmaceutical group, Novartis, has posted record-breaking net profits of SFr1.79 billion ($1.1 billion) for the first quarter, a 20 per cent rise on the previous year.

This content was published on April 18, 2002 - 08:28

According to a company statement, revenue also increased by 10 per cent, to SFr7.8 billon, compared to SFr7.22 for the same period last year.

swissinfo with agencies

This article was automatically imported from our old content management system. If you see any display errors, please let us know:

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?